TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Sports Participation Assessment
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Reinjury Assessment
Endpoint domain: Adverse events/effects
Primary endpoint: International Knee Documentation Committee Subjective Knee Evaluation Form (IKDC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient Reported Outcomes Measurement Information Systems (PROMIS)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Single Assessment Numeric Evaluation (SANE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Baby's heart rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Baby's respiratory rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Baby's oxygen saturation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients who respond to the feedback questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Final attrition rate
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: salivary expression of lncDQ786243
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Gut Microbial Community Structure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Combined incidence of major adverse cardiovascular and cerebrovascular events (MACCE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Activity of β-glucuronidase enzyme
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Abundance of β-glucuronidase-producing bacteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in gut microbiota composition, diversity, and functional capacity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients presenting at least one targetable genomic alteration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients presenting at least one targetable genomic alteration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline of the SPEED questionnaire score at Day 90
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Inspiratory O₂ concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Retention in SUD treatment
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: SUD Relapse Rate
Endpoint domain: Adverse events/effects
Primary endpoint: SUD engagement
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: MMR vaccination rate
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Digit Span Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Mental Flexibility
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Word Fluency Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Inadvertent eye movement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Per-vessel diagnostic sensitivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Per-vessel diagnostic specificity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Latency to T10 dermatome sensitive block
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Duration of the sensory block
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Functional Reach Test Distance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cough reflex
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Developmental assessment using Battelle Developmental Inventory (BDI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frailty indicator (TFI-T)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Chronic Disease and Health Problems Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Health Function
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Subjective symptoms of SUI
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Glucagon Suppression (G50)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Displacement of center of gravity during standing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Displacement of center of gravity during walking
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Glomerular Filtration rate (GFR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Combined detection of UDFF and SWE
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: T90 (time spent in SpO2 below 90%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Quality of life using the EQ-5D-5L questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Time to complete bone healing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of patients with treatment response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: indicators of organ dysfunction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Knowledge test
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in seropositivity from baseline for detection of viral shedding
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Change in clinical status from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in emotional functioning assessed by Beck Depression Inventory-II (BDI)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Session adherence
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Peak expiratory flow (PEF) Values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Mean daily ICS dose used
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: RMS Pictorial Scale (RMS-PS)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: level of awareness of parents about emergency management of avulsed permanent teeth
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Time to death from TGCV diagnosis
Endpoint domain: Mortality/survival
Primary endpoint: Milligrams of Morphine Equivalents (MME) Administered
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants Referred to Educational Program
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Completion of qualitative interview
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Wysa Engagement
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Number of subjects with a cancer event
Endpoint domain: Mortality/survival
Primary endpoint: Step counts at 24 and 48 hours post-operative
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of at Least Possibly Related Grade 3 Adverse Events (AE) and Serious Adverse Events (SAE)
Endpoint domain: Adverse events/effects
Primary endpoint: Concentration of ABNCoV2-specific Antibodies 14 Days Following First Vaccination
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Pain/Discomfort Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Delirium reporting
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fredericia-corrected QT interval
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Objective response per central review of antitumor activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: CBC analysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: PT, PTT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change in Sexual Desire Inventory (SDI-2) total score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Positive/Negative Percent Agreement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intracerebral arterial flows
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Inflammation in PET/CT scan
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Coping Self-efficacy
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Ratio between native and truncated procalcitonin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Freedom from any documented atrial arrhythmia off AADs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of positive cases of coronary artery disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Quality of life-SF 36
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: all-cause mortality at 1-year post-procedure
Endpoint domain: Mortality/survival
Primary endpoint: Percentage of subjects with none/trace or mild mitral regurgitation at 30 days post-procedure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in 10 km race time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Occurrence of an objective response (OR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Occurrence of CR
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Confirmed pregnancy rate
Endpoint domain: Mortality/survival
Primary endpoint: Occurrence of ectopic pregnancy
Endpoint domain: Adverse events/effects
Primary endpoint: Occurrence of uterine perforation
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of subjects with at least a 50% reduction in frequency of UUI events
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cortical connectivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Response times for nurses
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Concentration of bacterial 16S rDNA in stools
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Amino acid oxidation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: WOMAC function Score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Disease-related clinical reactions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of JHR
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of potential participants without smart devices
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Presence of microplastics and nanoplastics
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Sensitivity of NGS assay for ctDNA detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of C. acnes prosthetic joint infections management failure
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of adverse event linked to rifampicin
Endpoint domain: Adverse events/effects
Primary endpoint: number of participants developing major or minor complications
Endpoint domain: Adverse events/effects
Primary endpoint: Calprotectin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Photopic Contrast Sensitivity at 6 Cpd
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mesopic Contrast Sensitivity at 6 Cpd
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Photopic Resolution Acuity Using Landolt C's With a Glare Source
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Baseline in Ichthyosis Area Severity Index (IASI) Total Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: hospitalisation at 1 year
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: MRI change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Surgeon's feedback on ergonomics and safety
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Number of nurse visits
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Number of doctor visits
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Total PSS Score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in AaPO2 gradient
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Relative energy deficiency (REDs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Development of cellular and humoral immunity against SARS-CoV-2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Canine mobility
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Caries Arrest
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: The Scale of Patient Perception of Hospital Experience with Nursing Care (PPHEN)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Peripheral apoptosis (Fortilin)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peripheral apoptosis (Cytochrome c)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline in UMSARS Part I
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Incidences of severe adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: interdental papilla loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gene expression of molecular biomarkers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline score of the Brief Psychiatric Rating Scale-24
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change from baseline score of the Clinical Global Impression Scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change from baseline score of the Hamilton Anxiety Rating Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change from baseline score of the Hamilton Depression Rating Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Parent Mastery Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Proportion of patients for whom the desired dose of anti-CD19-CD3E-CAR-T cells can be successfully manufactured
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Clinical response for relapsed/Refractory SLE
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in microvascular angiotensin II type 2 receptor (AT2R)-mediated dilation response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Change in microvascular ang II-mediated constriction response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Prevalence of presumed advanced NASH
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Modified Falls Efficacy Scale
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Five-Dimensional European Quality of Life Scale (EQ-5D-3L)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of Participants Who Sought Cognitive Behavioral Therapy
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Mean total Quality of recovery (QoR-15) scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Vaccine literacy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Vaccine advocacy intention
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Vaccine attitudes
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: change from baseline of the IPAQ score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Serum Irisin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Ottawa Sitting Scale (OSS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: amount of gastric residual volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: occurrence of vomiting, constipation, and aspiration
Endpoint domain: Adverse events/effects
Primary endpoint: Safety of CAR T-cell therapy
Endpoint domain: Adverse events/effects
Primary endpoint: Desire for Social Distance
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Personal Stigma
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Attitudes towards those experiencing mental disorders
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Aggressiveness of prostate cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change of area of psoas muscle
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Number of participants with symptomatic intracranial hemorrhage
Endpoint domain: Adverse events/effects
Primary endpoint: CD56 endometrial NK cell frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: CD56 endometrial NK cell function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in HbA1c at Week 6
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in HbA1c at week 12
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Recurrence rate of CCA
Endpoint domain: Mortality/survival
Primary endpoint: liver fat content percentage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Detection rate of circulating biomarkers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Serum antibody
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in T cell response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in Gene expression profile
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Metabolites
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Incidence of postoperative pulmonary complication
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Number of Participants with Absolute Neutrophil Cell (ANC) Engraftment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Number of Participants with Platelet Engraftment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Workload perception
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Uncorrected Visual Acuity of 20/16 or better
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline Immunogenicity at 8 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Differences in moderate to vigorous physical activity at 8 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Differences in moderate to vigorous physical activity at 14 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Differences in moderate to vigorous physical activity at 20 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants Discontinuing From Study Therapy Due to an Adverse Event (AE)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants With Clinically Significant Abnormalities in 12-Lead Electrocardiogram (ECG) Findings
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Satisfactory knowledge score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Lung ventilation/perfusion matching
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Retention in Treatment 1
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Retention in Treatment 2
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change in clinical status for hypoxemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes